Overview

Phase II Pilot Study of Total Neoadjuvant Chemotherapy With FLOT VS Standard Perioperative FLOT in Patients With Gastric or GEJ Cancer

Status:
Not yet recruiting

Trial end date:
2029-01-01

Target enrollment:

Participant gender:

Summary

This is a randomized pilot study to evaluate and to compare the completion rates of Total Neoadjuvant chemotherapy with FLOT ( FLOT-TNT) and perioperative chemotherapy with FLOT ( FLOT-POP).

Phase:

Phase 2

Details

Lead Sponsor:

Baylor College of Medicine

Treatments:

Docetaxel
Fluorouracil
Leucovorin
Oxaliplatin